1. Brushless frequency motor, in great torque, free maintenance, no power pollution, quick in speed up and down.
2. 7” LCD Touch screen display which indicates the program, rotor No, speed, time, RCF and temperature.
3. CFC-free refrigerant, pre-cooling function ,double cycle cooling, cold and hot alternating easily, free environment pollution and precise in temperature control.
4. Microprocessor control , 100 programs in store, 10 kinds of acceleration and deceleration for your choice.
5. Over speed and imbalance protection.
6. Speed, RCF, time, temperature can be edited during running.
7. High quality steel centrifuge body , stainless steel chamber, built-in stainless steel explosion-proof protect sleeve, 3 tiers protection, safe and reliable.
8. Automatic door open & close, as well as anti-pinch function (Optional).
CDL7M Technical Parameter：
Max. Speed
7000rpm
Max. RCF
11650×g
Max. Capacity
6×2400ml (12*500ml blood bag）
Time Range
1~99h59min59s
RPM/RCF Convert
Yes
Noise (dB)
≤ 65
Temperature
-20 ~ 40℃
Acc/Dec
10 Kinds
Speed Accuracy
±20r/min
Temperature Accuracy
±1℃
Voltage(V/Hz)
AC 220V/380V 50HZ/60HZ
Size (W x D x Hmm)
940×890×1000mm
Net Weight(Kg)
570KG
Certificates
CE,ISO & Calibration report are available
Special rotor for blood bag separation
Order No.
Rotor No.
Max Speed (rpm)
Max Volume(ml)
Max. RCF（×g）
05202
Swing Rotor
4000
6×2x1000ml
5210
Document
CDL7M touch screen with special programs for blood bag separation, can get good performance for platelet, red cell, all parts separation of blood. 6x2x1000ml bucket suitable for blood bag separation. Also with automatical lid lock open and close function, also wind shield can open along with door open.
Model:
CDL7M
Annexin A1 (ANXA1) is a membrane protein that plays a role in innate and adaptive immunity by controlling the biosynthesis of inflammation, prostaglandins, and leukotriene mediators. This target is overexpressed in 97% of all samples from patients with with hairy cell leukemia, and is absent in other B-cell lymphomas. High ANXA1 expression is frequently associated with advanced stage esophageal and esophagogastric junction adenocarcinoma, and is also linked to advanced and metastatic disease states.
